Karakteristik Pasien Desensitisasi Cepat di RSUP Prof. Dr. I. G.N.G Ngoerah Denpasar Tahun 2022-2024
Main Article Content
Rapid desensitization is the primary management for patients with hypersensitivity reactions to certain medications when no alternative therapy to the primary drug is available. The rapid desensitization process is routinely performed at RSUP Prof Ngoerah Denpasar, but there is little data on the characteristics of patients undergoing this procedure. This study used a cross-sectional descriptive design with a total sample of 24 patient. The research samples were collected using consecutive sampling methods from patient medical records. The study was conducted at the inpatient unit of RSUP Prof. Dr. I.G.N.G Ngoerah from January 2022 to June 2024. The inclusion criteria were adult patients aged ≥ 18 years who underwent the rapid desensitization protocol and had complete medical records. The study found that the sample was predominantly female (62.5%) with an average age of 42.6 years (SD ± 18.0 years). The most common underlying disease among desensitization patients was Tuberculosis, affecting 13 individuals (54.1%), with the most frequent manifestation of hypersensitivity reactions being pruritus-urticaria in 100% of patients. The categories of drugs for which rapid desensitization was performed included antituberculosis drugs (OAT) in 14 patients (58.3%), with a few patients receiving NSAIDs (4.2%) and antipyretics (8.3%). Among the total 24 patients undergoing desensitization, a positive reaction was found in 9 patients (37.5%). The average time to drug exposure until the hypersensitivity reaction occurred was 10.1 days with a standard deviation of ± 11.2 days.
Cernadas, J. R., Brockow, K., Romano, A., Aberer, W., Torres, M. J., Bircher, A., Campi, P., Sanz, M. L., Castells, M., & Demoly, P. (2010). General considerations on rapid desensitization for drug hypersensitivity–a consensus statement. Allergy, 65(11), 1357–1366.
Chaiyakulsil, Chanapai, Sritipsukho, Paskorn, Satdhabudha, Araya, Bunjoungmanee, Pornumpa, Tangsathapornpong, Auchara, Sinlapamongkolkul, Phakatip, & Sritipsukho, Naiyana. (2022). An epidemiological study of pediatric COVID-19 in the era of the variant of concern. Plos One, 17(4), e0267035. https://doi.org/10.1371/journal.pone.0267035
Diantara, Lega Bisa, Hasyim, Hamzah, Septeria, Indah Puji, Sari, Dollyan Tamela, Wahyuni, Gusti Tri, & Anliyanita, Roza. (2022). Tuberkulosis Masalah Kesehatan Dunia: Tinjauan Literatur. Jurnal’Aisyiyah Medika, 7(2).
Doña, I., Blanca-Lopez, N., Torres, M. J., García-Campos, J., García-Núñez, I., Gómez, F., Salas, M., Rondón, C., Canto, M. G., & Blanca, M. (2012). 7 drug hypersensitivity reactions: response patterns, drug involved, and temporal variations in a large series of patients. Journal of Investigational Allergology and Clinical Immunology, 22(5), 363.
Fabrizio, Franceschini, Paolo, Bottau, Silvia, Caimmi, Fabio, Cardinale, Giuseppe, Crisafulli, Lucia, Liotti, Francesca, Saretta, Roberto, Bernardini, Francesca, Mori, & Carlo, Caffarelli. (2019). Mechanisms of hypersensitivity reactions induced by drugs. Acta Bio Medica: Atenei Parmensis, 90(Suppl 3), 44.
Fekih, L., Fenniche, S., Boussoffara, L., Hassene, H., Abdelghaffar, H., Belhabib, D., & Mohamed, L. Megdiche. (2010). Manifestations d’hypersensibilité aux antituberculeux. Revue Des Maladies Respiratoires, 27(7), 673–678.
Giavina-Bianchi, Pedro, Aun, Marcelo Vivolo, Galvão, Violeta Régnier, & Castells, Mariana. (2015). Rapid desensitization in immediate hypersensitivity reaction to drugs. Current Treatment Options in Allergy, 2, 268–285. https://doi.org/10.1007/s40521-015-0060-2
Giri, Putu Agus Semara Putra. (2020). Mereduksi Kecemasan Dengan Teknik Desensitisasi Sistematis. Widyadari, 21(1).
Irmawati, Yesi. (2020). Desensitisasi Diri dalam Mengurangi Tingkat Kecemasan Berkomunikasi Ketika Presentasi Mahasiswa BKI IAIN Parepare. IAIN Parepare.
Khairunnisa, Sunniyah. (2024). Analisis Dampak Pencemaran Radiasi Gelombang Elektromagnetik dari Penggunaan Laptop Terhadap Gejala Hipersensitivitas pada Mahasiswa Fkm Usu Tahun 2024. Universitas Sumatera Utara.
Mansour, A. Ben, Daghfous, H., Saad, S. Ben, Bellali, H., & Tritar, F. (2021). Ultra-rapid desensitization with rifampicin syrup. Revue Française d’Allergologie, 61(8), 579–582.
Mar’iyah, Khusnul, & Zulkarnain, Zulkarnain. (2021). Patofisiologi penyakit infeksi tuberkulosis. Prosiding Seminar Nasional Biologi, 7(1), 88–92.
Pagani, Silvia, Lombardi, Niccolò, Crescioli, Giada, Vighi, Giuditta Violetta, Spada, Giulia, Romoli, Isabella, Andreetta, Paola, Capuano, Annalisa, Marrazzo, Eleonora, & Marra, Anna. (2021). Analysis of fatal adverse drug events recorded in several Italian emergency departments (the MEREAFaPS study). Internal and Emergency Medicine, 16(3), 741–748.
Siripassorn, Krittaecho, Ruxrungtham, Kiat, & Manosuthi, Weerawat. (2018). Successful drug desensitization in patients with delayed-type allergic reactions to anti-tuberculosis drugs. International Journal of Infectious Diseases, 68, 61–68.
